Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib.
暂无分享,去创建一个
Ricardo C T Aguiar | R. Aguiar | J. Aster | M. Shipp | Jon C Aster | Kathryn Wilkinson | Elvira R P Velloso | Luiz Fernando Lopes | Charles Lee | Margaret A Shipp | L. F. Lopes | E. Velloso | Charles Lee | Kathryn N. Wilkinson
[1] M. Tanimoto,et al. Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. , 1997, Blood.
[2] R. Berger,et al. Fusion of Huntingtin Interacting Protein 1 to Platelet-Derived Growth Factor β Receptor (PDGFβR) in Chronic Myelomonocytic Leukemia With t(5;7)(q33;q11.2) , 1998 .
[3] Todd R. Golub,et al. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.
[4] M. K. Magnússon,et al. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. , 2001, Blood.
[5] Peter Marynen,et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. , 2003, The New England journal of medicine.
[6] M. K. Magnússon,et al. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene. , 2002, Blood.
[7] C. Görg,et al. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease , 1997, British journal of haematology.
[8] B. Rotoli,et al. AlphaIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5). , 1999, Haematologica.
[9] F. Ishida,et al. Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation. , 1993, Cancer genetics and cytogenetics.
[10] R. Berger,et al. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). , 1998, Blood.
[11] S. Jin,et al. Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase* , 2001, The Journal of Biological Chemistry.
[12] H. Kempski,et al. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils , 1994, British journal of haematology.
[13] B. Druker,et al. STI571: a paradigm of new agents for cancer therapeutics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] L. Koenderman,et al. An Improved Method for the Isolation of Eosinophilic Granulocytes From Peripheral Blood of Normal Individuals , 1988, Journal of leukocyte biology.
[15] T M Chused,et al. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. , 1981, Blood.
[16] A. Grañena,et al. Refractory anaemia with hypereosinophilia and clonal abnormal metaphases detected only in the neutrophilic granulopoietic series. , 1994, Acta haematologica.
[17] J. Kutok,et al. H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). , 2001, Blood.
[18] R. Aguiar,et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. , 1995, Leukemia.
[19] N. Cross,et al. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta. , 2002, Acta haematologica.
[20] R. Aguiar,et al. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. , 1997, Blood.
[21] A Azzarà,et al. Detection of eosinophils in whole blood samples by flow cytometry. , 1998, Cytometry.
[22] B. Bain,et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. , 2002, The New England journal of medicine.
[23] R. Aguiar,et al. PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest. , 1999, Blood.
[24] S. Lawler,et al. A myeloproliferative disease in two infants associated with eosinophilia and chromosome t(1;5) translocation , 1987, British journal of haematology.